Production (Stage)
PureTech Health plc
PRTC
$18.20
-$0.80-4.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 328.10% | 0.00% | -2.65% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -3.14% | 0.00% | -3.10% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -584.54% | 0.00% | -32.81% | 0.00% |
| Change in Net Operating Assets | 0.00% | 139.64% | 0.00% | -209.90% | 0.00% |
| Cash from Operations | 0.00% | 32.07% | 0.00% | -96.19% | 0.00% |
| Capital Expenditure | 0.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00% | -64.36% | 0.00% | -31.64% | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00% | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -59.42% | 0.00% | 324.71% | 0.00% |
| Cash from Investing | 0.00% | -98.15% | 0.00% | 325.48% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -5.95% | 0.00% | -4.70% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | 0.00% | 366.15% | 0.00% |
| Repurchase of Common Stock | 0.00% | 98.96% | 0.00% | -760.26% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -63.29% | 0.00% | -- | -- |
| Cash from Financing | 0.00% | 156.63% | 0.00% | -184.25% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00% | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -123.71% | 0.00% | 173.63% | 0.00% |